Control group:The control group was followed up after operation.

2 trials

Sponsors

Sun Yat-sen University Cancer Center, Jining Medical University Affiliated Hospital

Conditions

Non-small cell lung cancernon-small cell lung cancer

Phase 2

A multicenter, randomized, controlled, open Phase II trial of adjuvant ectinib (24 months) after complete resection of non-small cell lung cancer (NSCLC) with high-risk factors in Stage IA

RecruitingChiCTR2400088956

Sun Yat-sen University Cancer Centernon-small cell lung cancer

Start: 2024-06-24Updated: 2024-09-02

Clinical Study on Adjuvant Targeted Therapy with EGFR Mutation after Surgery for Stage IA Non-small Cell Lung Cancer

Active, not recruitingChiCTR2400089820

Jining Medical University Affiliated HospitalNon-small cell lung cancer

Start: 2024-09-19Updated: 2025-04-28